Atopic Foot Dermatitis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2023-12-22
Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Moderate-to-Severe Atopic Hand and Foot Dermatitis (Liberty-AD-HAFT) [Phase 3]
Phase 3 trial evaluating dupilumab for moderate-to-severe atopic hand and foot dermatitis has completed with posted results.